The migration to commercial-scale quantities was a direct response to customer demand for active, stable and flexible catalysts for use in asymmetric transfer hydrogenation reactions.

The technology, originally developed by Professor Martin Wills at the University of Warwick, has been successfully launched working in close collaboration with customers to develop new API manufacturing applications. In 2013, JMCCT began work to expand the availability of the current 2 variants of tethered catalyst to multi-kilograms scale. The tethered catalyst offer is now available for use in both hydrogenation and transfer hydrogenation, and has shown exceptional results in increasing activity and robustness against polyfunctionalised substrates.

Plans to expand the current product line are underway, supported by the UK Government’s technology strategy board’s recent grant funding of a joint research program between JMCCT and the University of Warwick for the development of phosphine-free hydrogenation catalysts.

"The availability at commercial scale of the tethered catalyst technology is the demonstration of our continuous commitment to the advancement of chiral chemocatalysis" noted Daren Bryce, Commercial Manager at JMCCT. "We believe the successful collaboration with Warwick University and the launch of further tethered catalysts throughout 2014 makes the JMCCT offer the most active, stable and flexible catalytic technology on the market."

Ruthenium(II) catalysts for asymmetric transfer hydrogenation reactions are often referred to as tethered catalysts because the chiral and arene ligand components are covalently linked, helping the chiral component to remain in the correct conformation, and preventing the arene component from rotating. This gives higher activity and stability to the transfer hydrogenation catalyst, making its performance much more similar to pressure hydrogenation catalysts, but without the need of specialised manufacturing equipment. In particular, JMCCT tethered catalysts have proven applicable to traditionally difficult substrates such as alpha-chloroacetophenone, propargyl ketones and polyfunctionalised molecules, and also shown excellent results in other client applications.